Objective: Single-cell RNA sequencing studies have revealed that the type-2 diabetes associated two-pore domain K 
INTRODUCTION
Somatostatin is a potent inhibitory peptide, which regulates many physiological processes, such as hormone secretion, neurotransmission, gastric function, and cell proliferation. Somatostatin signals through plasma membrane G ai -coupled receptors, suppressing cellular function through a number of mechanisms including inhibition of cAMP-dependent pathways and activation of inward-rectifier K þ channels. In most cases, secreted somatostatin acts locally to regulate the activity of surrounding cells [1] . This is exemplified by intraislet somatostatin release, which inhibits glucagon and insulin secretion [2e4] . Islet somatostatin secretion is increased by elevated blood glucose levels [5] , providing a paracrine feedback mechanism to curtail excessive insulin and glucagon secretion and minimize large fluctuations in glycemia. Although the necessity of proper islet somatostatin secretion for glucose homeostasis is increasingly appreciated, the molecular mechanisms underlying d-cell function remain poorly understood. Emerging data suggest that dysregulated islet somatostatin secretion contributes to hyperglycemia in type 1 and type 2 diabetes mellitus (T2DM), highlighting the importance of determining the molecular physiology of d-cells [2,6e9] .
Somatostatin secretion requires extracellular Ca 2þ influx through voltage-dependent Ca 2þ channels (VDCCs) [10e12] . VDCC opening is determined by the plasma membrane potential (V m ), which is largely controlled by the activity of hyperpolarizing K þ channels such as ATPsensitive K þ (K ATP ) channels. Pharmacological or metabolic inhibition of K ATP channels stimulates Ca 2þ entry and somatostatin secretion [3, 9, 13] . However, d-cells lacking functional K ATP channels still exhibit glucose-stimulated somatostatin secretion (GSSS), indicating that other mechanisms in addition to K ATP channels contribute to GSSS [11] . Previous studies demonstrate that GSSS also relies upon paracrine stimulation by b-cells and Ca 2þ -induced Ca 2þ release (CICR)
from the d-cell ER [9, 11] . CICR is sensitive to both cytoplasmic Ca 2þ and total ER Ca 2þ content [14e16] . Glucose metabolism accelerates d-cell sarco/endoplasmic reticulum Ca 2þ -ATPase (SERCA) activity, resulting in elevated ER Ca 2þ content, which enhances CICR [11] . Pharmacological inhibition of SERCA activity and subsequent depletion of ER Ca 2þ significantly reduces somatostatin secretion, indicating that d-cell ER Ca 2þ stores serve a critical role in GSSS [11, 17] [21] . TALK-1 regulates b-cell ER Ca 2þ handling by conducting K þ countercurrents across the ER membrane which promote ER Ca 2þ leak; inhibiting TALK-1 channel activity augments ER Ca 2þ stores [22] . TALK-1 channels are also implicated in T2DM pathogenesis through a non-synonymous polymorphism (rs1535500, encoding TALK-1 A277E) which causes a gain-of-function in TALK-1 channel activity [21] . The rs1535500 polymorphism is associated with impaired insulin secretion in T2DM patients and increased T2DM susceptibility [23e27] . These data, along with the prominent expression of TALK-1 channels in the islet, suggest that defects in d-cell function induced by TALK-1 A277E may contribute to islet dysfunction and exacerbate hyperglycemia in patients with T2DM. Given the role TALK-1 channels serve in regulating ER Ca somatostatin signaling, and contribute to an improved understanding of the molecular mechanisms underlying GSSS.
MATERIALS AND METHODS

Chemicals
All chemicals were purchased from SigmaeAldrich (St. Louis, MO) unless specified otherwise.
Biological materials and study approval
The mice used in this study were 10e15 week-old males on a C57Bl6/ J background. Mice were housed in a 12-hour light/dark cycle with access to standard chow (Lab Diets, 5L0D) ad libitum. Wild-type (WT) and TALK-1 KO transgenic mice expressing tdRFP specifically in somatostatin-positive cells (RFP d-cells) were generated by crossing mice expressing Sst-IRES-Cre [28] with mice expressing a tdRFP fluorescent reporter preceded by a loxP-flanked STOP cassette [29] . Transgenic mice expressing GCaMP6s specifically in somatostatinpositive cells were generated by crossing WT and TALK-1 KO mice expressing Sst-IRES-Cre with those possessing the genetically encoded Ca 2þ indicator GCaMP6s preceded by a loxP-flanked STOP cassette [36] . Mouse islets were isolated by digesting the pancreas with collagenase P (Roche) and performing density gradient centrifugation as previously described [30] . We obtained human islets from adult non-diabetic donors from multiple isolation centers organized by the Integrated Islet Distribution Program (human islet donor characteristics are provided in Table S1 ). Mouse and human islets were cultured in RPMI 1640 (Gibco) containing 15% fetal bovine serum (FBS), 100 IU•ml À1 penicillin, and 100 mg ml À1 streptomycin, in an incubator maintained at 37 C, 5% CO 2 . Although the concentration of glucose in RPMI 1640 (11 mM) is higher than typical resting glucose in humans (5.6 mM), human cells are more amenable to patch clamp recording when cultured under these conditions. Moreover, we do not observe significant differences in d-cell electrical excitability when cultured with high (11 mM) and low (1 mM) glucose. Islets and cells were seeded to poly-D-lysine-coated 35 mm glass-bottom dishes (CellVis). In experiments using single islet cells, islets were triturated in 0.0075% trypsin-EDTA prior to plating. Dispersed cells were cultured for approximately 6 h in 100 mL of medium prior to being refed with 2 mL of fresh medium. In human d-cell experiments, cells were transfected with TALK-1 DN-or mCherry-expressing plasmids and identified by post-staining for somatostatin as previously described [21] . Briefly, cells were transfected for 18 h using 1 mL Lipofectamine 3000 and 1 mL P3000 (Thermo Fisher) with 400 ng DNA in a total volume of 100 mL of the transfection mixture. After 18 h the cells were re-fed with fresh media. For Ca 2þ imaging experiments using primary human d-cells, cells were infected 48 prior to imaging with PsstmCherry adenovirus to facilitate identification of d-cells [31] . All mouse procedures performed in this study were done in compliance with protocols reviewed and approved by the Vanderbilt University Institutional Animal Care and Use Committee, according to guidelines set forth by the National Institutes of Health.
Immunofluorescence
Paraffin-embedded mouse and human pancreas sections were processed and stained as previously described (human donor information is provided in Table S2 ) [21] . Sections were stained using primary antibodies against somatostatin (Santa Cruz Biotechnology sc-7819: 1:250), TALK-1 (Novus Biologicals #NBP1-83071; 1:175) or TALK-1a (Antibody Verify AAS72353C; 1:250), glucagon (Proteintech #15954-I-AP: 1:500), and the endoplasmic reticulum marker GRP94 (Novus Biologicals #NB300-619; 1:100); secondary antibodies used were Alexa Fluor 488-conjugated donkey anti-rabbit (Jackson Immunoresearch #711-546-152; 1:300), DyLight 650-conjugated donkey antigoat (Thermo Fisher #SA5-10089; 1:250), and Cy3-conjugated donkey anti-mouse (Jackson Immunoresearch #715-166-150; 1:500).
2.4. Calcium imaging Ca 2þ imaging was performed as previously described using epifluorescent or confocal miscroscopy with Ca 2þ dyes (Fura-2 AM, Cal520-AM, or Cal590-AM) or genetic indicators (GCaMP3 or GCaMP6s) [22] . Further details on the protocols used to measure Ca 2þ c can be found in the supplemental data.
Cross-correlation analysis
The glucose-mediated synchronization of islet b-and d-cell Ca 2þ oscillations was calculated using the cross-correlation function of Clampfit 10. Changes in the GCaMP6s signal of individual d-cells within an islet were correlated to Cal590-AM signal in the same islet at 1 mM glucose, 11 mM glucose, and 11 mM glucose with 50 mM CPA. As Cal590-AM was utilized as an indicator of b-cell Ca 2þ c , areas displaying GCaMP6s [21] . Glucagon and somatostatin secretion measurements from static incubations were performed as previously described [34] . Somatostatin was measured using a fluorescent EIA kit according to the manufacturer's instructions (Phoenix Pharmaceuticals #FEK-060-03).
Statistical analysis
The data are shown as recordings that are averaged or representative of results obtained from at least three independent cultures. The values presented are the mean AE SE. Statistical differences between means were assessed using two-tailed unpaired Student's t-test unless stated otherwise. A P < 0.05 was considered as significant.
RESULTS
TALK-1 channels are expressed in d-cells
We first sought to determine whether functional TALK-1 channels are expressed in the ER of d-cells. Somatostatin-positive cells from mouse and human pancreas sections displayed strong intracellular localization of TALK-1, which resembled the staining pattern for an ER marker (GRP94). This suggests that, as with b-cells, TALK-1 may serve a role in the ER of islet d-cells (Figure 1AeD ) [22] . As TALK-1 expression has also been reported in gastric d-cells [19] , we stained paraffin embedded sections of human duodenum and stomach for TALK-1 and somatostatin. In agreement with transcriptome analyses, TALK-1 was detectable in gastric somatostatin-positive cells (Figs. S1A,B) . We next went on to test whether TALK-1 forms functional K þ channels in mouse islet d-cells using TALK-1 deficient mice (TALK-1 KO) [21] . We dispersed these islet cell preparations and recorded whole-cell K2P
currents from single RFP d-cells, which were significantly reduced in d-cells from TALK-1 KO mice when compared to WT ( Figure 1E ). To assess whether TALK-1 also forms a functional channel in human dcells, we expressed a TALK-1 dominant-negative (DN) mutant to inhibit endogenous TALK-1 channel activity [21] . The TALK-1 DN relies on a mutation (G110E) in the K þ selectivity filter that abolishes K þ conductance upon interaction with wild-type TALK-1; the TALK-1 DN construct also possesses an mCherry fluorescent reporter separated from TALK-1 DN by a P2A sequence, facilitating identification of transfected cells [21] . Expression of the TALK-1 DN in single human dcells (confirmed by post-staining for somatostatin) resulted in inhibition of whole-cell K2P currents ( Figure 1F ). These observations indicate that TALK-1 forms K þ channels in d-cells. Physiological d-cell function depends upon the islet microenvironment which enables paracrine feedback mechanisms between b-, a-, and d-cells [9, 35, 36] . Therefore, we also examined how TALK-1 channel activity impacts d-cell cytosolic Ca Figure 4D ), but we detected no difference in the plateau V m from which action potentials fire ( Figure 4E ). There were also no appreciable differences in the pattern or frequency of action potentials in TALK-1 KO d-cells when compared to WT d-cells; however, action potential upstroke and afterhyperpolarization (AHP) had larger amplitudes in KO d-cells (Table 1) . We also measured VDCC currents to assess whether changes in Ca 
CICR is enhanced in TALK-1 KO d-cells
One of the mechanisms proposed to underlie the glucose-induced increase in somatostatin secretion is enhanced CICR [11] . Figs. S2A,B) . The CPA-induced rate of ER Ca 2þ release was also accelerated in TALK-1 KO compared to WT d-cells (Fig. S2C) . To 953.3 AE 78.9 AUC, P < 0.01, Figure 5D ). This is consistent with past reports that documented sustained CICR over a period of several minutes in the presence of a stimulus [44, 45] . To determine whether increased ER Ca the V m and VDCCs, and highlight that somatostatin secretion is very sensitive to ER Ca 2þ release.
Glucagon secretion is reduced from TALK-1 KO islets
The acute sensitivity of a-cells to somatostatin under low glucose conditions is highlighted by the several-fold increase in glucagon secretion when somatostatin signaling is blocked [3, 46, 47] . Thus, somatostatin exerts an inhibitory tone on a-cells in low glucose, and increased basal somatostatin secretion leads to reduced glucagon secretion [3] . In TALK-1 KO islets, we found that glucagon release is significantly impaired under low glucose conditions (Figure 6AeC ).
While RNA sequencing of sorted a-cells has revealed high levels of KCNK16 mRNA (gene encoding TALK-1), TALK-1 protein is not detected in mouse or human a-cells [8, 21, 48, 49] . It is not clear why KCNK16 mRNA is present in a-cells but not TALK-1 protein; however, Blodgett and colleagues also observed high levels of insulin mRNA but not protein in a-cells [48] . These observations underscore the importance of functional experimentation in support of transcriptome analysis and that the molecular mechanisms regulating islet-cell hormone mRNA expression are still incompletely understood. To further verify the absence of TALK-1 channels in a-cells, we recorded a-cell K2P currents, but we did not detect a difference between WT and TALK-1 KO a-cells ( Figure 6D ). Immunofluorescent analysis of human pancreas sections using two different TALK-1 antibodies failed to demonstrate TALK-1 in a-cells (Figure 6E ), and expression of the TALK-1 DN mutant in human a-cells (confirmed by post-staining) had no effect on K2P currents ( Figure 6F ). As TALK-1 channels are not expressed in a-cells, it is likely that reduced glucagon secretion from TALK-1 KO islets was due to paracrine effects. While insulin is a paracrine inhibitor of glucagon secretion [50] , insulin secretion from TALK-1 KO islets was indistinguishable from WT islets in 1 mM glucose [21] . This suggests that the reduced glucagon secretion observed in TALK-1 KO islets is a consequence of increased somatostatin secretion.
Somatostatin receptor signaling inhibits a-cell function through multiple mechanisms, including reduction of cellular cAMP levels [50] , suppression of glucagon granule exocytosis [51] , and activation of V mhyperpolarizing K þ currents [52e54]. As V m hyperpolarization limits a-cell Ca 2þ influx and glucagon secretion [55] , we hypothesized that increased basal somatostatin release in TALK-1 KO islets would impact a-cell Ca 2þ c dynamics. We tested this possibility by measuring a-cell Ca 2þ c oscillations in WT and TALK-1 KO islets, using mice which express the genetically encoded Ca 2þ indicator GCaMP3 specifically in a-cells [34] . In agreement with findings that somatostatin suppresses a-cell electrical activity and increases in Ca 2þ c [54, 56] , we found that significantly fewer TALK-1 KO a-cells exhibited Ca 2þ c oscillations in low (1 mM) glucose when compared to controls ( Figure 7A ,B, and E). However, disrupting intraislet somatostatin paracrine signaling by dispersing islets into single cells normalized the oscillation frequency of WT and TALK-1 KO a-cells ( Figure 7C ,D, and E). Similarly, we found a tendency towards lower Ca 2þ c in intact islet TALK-1 KO a-cells, a difference which was not found in single TALK-1 KO a-cells ( Figure 7F ). Single a-cells were still capable of responding to somatostatin, as addition of 10 nM somatostatin caused a transient suppression of Ca 2þ oscillations ( Figure 7C,D) , consistent with its effects on a-cell electrical activity [54] . To ascertain the relationship between somatostatin signaling and TALK-1 KO a-cell function, we measured glucagon secretion from WT and TALK-1 KO islets in the presence of the SSTR2 antagonist CYN154806. Blockade of SSTR2, which is the dominant a-cell SSTR [56, 57] , potently increased glucagon secretion under both low and high glucose conditions and abrogated the reduced glucagon secretion of TALK-1 KO islets ( Figure 7G ). Together, these findings indicate that TALK-1 modulation of d-cell somatostatin secretion impacts a-cell Ca 2þ handling and glucagon secretion.
DISCUSSION
Although it is increasingly clear that islet d-cells serve an important role in glucose homeostasis, our understanding of the mechanisms underlying d-cell stimulus-secretion coupling has lagged behind that of b-and a-cells. CICR contributes to GSSS [11] , but the molecular components which tune d-cell CICR have remained largely unknown.
Recent observations identified TALK-1 channels as important enhanced ER Ca 2þ release [11] . Accordingly, depletion of ER Ca 2þ (by inhibiting SERCAs) strongly inhibits somatostatin secretion [11, 17, 58] .
The results presented here demonstrate that glucose metabolism augments d-cell Ca 2þ c through increased CICR, as hypothesized by Zhang and colleagues [11] . We also found that depletion of ER Ca 2þ stores significantly blunted depolarization-induced Ca 2þ c transients, strongly supporting the hypothesis that Ca 2þ release from the d-cell ER makes a substantial contribution to GSSS [11] . These data emphasize that metabolic enhancement of d-cell ER Ca 2þ stores and subsequent CICR is critical for somatostatin secretion. Our findings indicate that TALK-1 channels provide a control mechanism for d-cell ER Ca 2þ handling and somatostatin secretion. In bcells TALK-1 channels act as a countercurrent for ER Ca 2þ leak [22] . [22] . CICR provides a glucose-dependent mechanism to amplify d-cell
Ca 2þ c levels and somatostatin secretion, and is conceivably tuned by [19] , and the findings of this study suggest that TALK-1 channels may serve a role in regulating these responses. Interestingly, one of the few known physiological regulators of TALK-1 currents is extracellular pH [63] . While pH fluctuations around the islet are not expected to be of sufficient magnitude to impact islet cell TALK-1 currents, pH changes in the gastrointestinal tract could regulate gastric d-cell Ca 2þ handling and somatostatin secretion. Future studies will define the mechanisms which control the expression and activity of both islet and gastric d-cell Inhibition of islet TALK-1 channel activity inhibits glucagon secretion while stimulating insulin and somatostatin secretion. Therefore, inhibition of TALK-1 channels could be beneficial in patients with T2DM. Indeed, TALK-1 KO mice fed a high-fat diet exhibit reduced fasting glycemia [21] . The findings described here suggest that the lower fasting glycemia in TALK-1 KO mice may arise due to elevated somatostatin secretion and reduced glucagon secretion, in addition to increased insulin secretion. Increased glucagon secretion at 1 mM glucose in the presence of an SSTR2 inhibitor highlights the importance of d-cell paracrine signaling to the inhibitory action of TALK-1 on glucagon secretion. While the basis for this effect remains to be determined, it is likely related to decreased a-cell Ca 2þ c and cAMP levels. SSTR2 signaling in a-cells inhibits adenylyl cyclase synthesis of cAMP and also activates G protein-coupled inwardly-rectifying K þ channels, which hyperpolarize V m and inhibit VDCCs [70] . Interestingly, SSTR2 signaling has been shown to reduce a-cell cAMP only at low glucose [71] . Our observations together with these previously published data highlight that a-cells are very sensitive to somatostatin at low glucose, but that alternate mechanisms predominate at high glucose. Taken together, these data also indicate that defects that lead to increases in TALK-1 channel activity may contribute to fasting hyperglycemia under metabolically stressful conditions. In agreement with this hypothesis, a gain-of-function polymorphism in TALK-1 (rs1535500, encoding TALK-1 A277E) is associated with an increased risk for T2DM [24, 25, 27] . This polymorphism would be predicted to reduce ER Ca 2þ levels [22] . In d-cells, increased TALK-1 channel activity would diminish CICR and lower somatostatin secretion. In turn, decreased somatostatin secretion would be expected to increase glucagon secretion and contribute to hyperglycemia. In addition, rs1535500-induced defects in b-cell function may impair b-cell to d-cell signaling, further contributing to hyperglycemia by allowing inappropriately elevated glucagon secretion. Further studies are needed to understand TALK-1 regulation of d-cells and the intraislet feedback mechanisms which contribute to glucose control in health and disease.
In conclusion, this study reveals that TALK-1 channels serve a key role in shaping d-cell Ca 2þ c and controlling somatostatin secretion by modulating d-cell ER Ca 2þ handling. We find that TALK-1 channel activity regulates d-cell CICR, limiting elevations in Ca 2þ c and somatostatin secretion. Our data also suggest that defects which lead to increases in TALK-1 channel activity (such as those induced by rs1535500) may participate in the pathogenesis of T2DM by negatively impacting d-cell function, contributing to elevated glucagon release.
These observations improve our understanding of the molecular mechanisms controlling d-cell stimulus-secretion coupling and highlight the potential clinical utility of TALK-1 channels as a therapeutic target to reduce elevated glucagon secretion in patients with T2DM. 
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